{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T17:10:31Z","timestamp":1773681031454,"version":"3.50.1"},"reference-count":43,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2010,7,1]],"date-time":"2010-07-01T00:00:00Z","timestamp":1277942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2010,7]]},"DOI":"10.1016\/j.lfs.2010.05.002","type":"journal-article","created":{"date-parts":[[2010,5,13]],"date-time":"2010-05-13T20:38:05Z","timestamp":1273783085000},"page":"9-16","source":"Crossref","is-referenced-by-count":10,"title":["Hypoxia inducible factor-1 improves the negative functional effects of natriuretic peptide and nitric oxide signaling in hypertrophic cardiac myocytes"],"prefix":"10.1016","volume":"87","author":[{"given":"Tao","family":"Tan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter M.","family":"Scholz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harvey R.","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.lfs.2010.05.002_bib1","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.pharmthera.2004.04.004","article-title":"Implications of the natriuretic peptide system in the pathogenesis of heart failure: diagnostic and therapeutic importance","volume":"102","author":"Abassi","year":"2004","journal-title":"Pharmacology & Therapeutics"},{"issue":"2","key":"10.1016\/j.lfs.2010.05.002_bib2","doi-asserted-by":"crossref","first-page":"H901","DOI":"10.1152\/ajpheart.00715.2007","article-title":"Prevention of HIF-1 activation and iNOS gene targeting by low-dose cadmium results in loss of myocardial hypoxic preconditioning in the rat","volume":"294","author":"Belaidi","year":"2008","journal-title":"American Journal of Physiology \u2014 Heart and Circulatory physiology"},{"issue":"1","key":"10.1016\/j.lfs.2010.05.002_bib3","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1161\/01.CIR.0000078635.89229.8A","article-title":"Hearts from rodents exposed to intermittent hypoxia or erythropoietin are protected against ischemia\u2013reperfusion injury","volume":"108","author":"Cai","year":"2003","journal-title":"Circulation"},{"issue":"Pt 2","key":"10.1016\/j.lfs.2010.05.002_bib4","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1113\/jphysiol.2002.017749","article-title":"Nitric oxide inhibits neuroendocrine Ca(V)1L-channel gating via cGMP-dependent protein kinase in cell-attached patches of bovine chromaffin cells","volume":"541","author":"Carabelli","year":"2002","journal-title":"Journal of Physiology"},{"issue":"5","key":"10.1016\/j.lfs.2010.05.002_bib5","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1157\/13087900","article-title":"Cardiac hypertrophy: molecular and cellular events","volume":"59","author":"Carreno","year":"2006","journal-title":"Revista Espa\u00f1ola de Cardiolog\u00eda"},{"issue":"3","key":"10.1016\/j.lfs.2010.05.002_bib6","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1179\/016164107X230135","article-title":"Effects of deferoxamine on blood\u2013brain barrier disruption and VEGF in focal cerebral ischemia","volume":"30","author":"Chi","year":"2008","journal-title":"Neurological Research"},{"issue":"3","key":"10.1016\/j.lfs.2010.05.002_bib7","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.biocel.2004.08.012","article-title":"Hypoxia-inducible factor 1: regulation by hypoxic and non-hypoxic activators","volume":"37","author":"Dery","year":"2005","journal-title":"The International Journal of Biochemistry & Cell Biology"},{"issue":"5652","key":"10.1016\/j.lfs.2010.05.002_bib8","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1126\/science.1088805","article-title":"Redistribution of intracellular oxygen in hypoxia by nitric oxide: effect on HIF1alpha","volume":"302","author":"Hagen","year":"2003","journal-title":"Science"},{"issue":"13","key":"10.1016\/j.lfs.2010.05.002_bib9","doi-asserted-by":"crossref","first-page":"9038","DOI":"10.1074\/jbc.274.13.9038","article-title":"Inhibition of hypoxia-inducible factor 1 activation by carbon monoxide and nitric oxide. Implications for oxygen sensing and signaling","volume":"274","author":"Huang","year":"1999","journal-title":"Journal of Biological Chemistry"},{"issue":"3","key":"10.1016\/j.lfs.2010.05.002_bib10","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1084\/jem.20061943","article-title":"Dietary copper supplementation reverses hypertrophic cardiomyopathy induced by chronic pressure overload in mice","volume":"204","author":"Jiang","year":"2007","journal-title":"The Journal of Experimental Medicine"},{"issue":"9","key":"10.1016\/j.lfs.2010.05.002_bib11","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1016\/j.peptides.2006.04.011","article-title":"T4-induced cardiac hypertrophy disrupts cyclic GMP mediated responses to brain natriuretic peptide in rabbit myocardium","volume":"27","author":"Katz","year":"2006","journal-title":"Peptides"},{"issue":"2","key":"10.1016\/j.lfs.2010.05.002_bib12","doi-asserted-by":"crossref","first-page":"E25","DOI":"10.1161\/hh0202.104923","article-title":"Early expression of myocardial HIF-1alpha in response to mechanical stresses: regulation by stretch-activated channels and the phosphatidylinositol 3-kinase signaling pathway","volume":"90","author":"Kim","year":"2002","journal-title":"Circulation Research"},{"issue":"4","key":"10.1016\/j.lfs.2010.05.002_bib13","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/S0006-291X(02)02029-6","article-title":"Effects of nitric oxide donors on vascular endothelial growth factor gene induction","volume":"296","author":"Kimura","year":"2002","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"3","key":"10.1016\/j.lfs.2010.05.002_bib14","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/S0008-6363(98)00314-9","article-title":"Regulation of basal myocardial function by NO","volume":"41","author":"Kojda","year":"1999","journal-title":"Cardiovascular Research"},{"issue":"1","key":"10.1016\/j.lfs.2010.05.002_bib15","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1161\/01.RES.0000200398.52220.cc","article-title":"Induction of HIF-1alpha and iNOS with siRNA: a novel mechanism for myocardial protection","volume":"98","author":"Lefer","year":"2006","journal-title":"Circulation Research"},{"issue":"4","key":"10.1016\/j.lfs.2010.05.002_bib16","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s11897-004-0007-6","article-title":"Type 5 phosphodiesterase inhibition in heart failure and pulmonary hypertension","volume":"1","author":"Lewis","year":"2004","journal-title":"Current Heart Failure Reports"},{"issue":"3","key":"10.1016\/j.lfs.2010.05.002_bib17","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.jacc.2006.05.020","article-title":"Natriuretic peptides and cardiac hypertrophy","volume":"48","author":"London","year":"2006","journal-title":"Journal of the American College of Cardiology"},{"issue":"3","key":"10.1016\/j.lfs.2010.05.002_bib18","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0031-6997(24)01457-1","article-title":"Guanylyl cyclases and signaling by cyclic GMP","volume":"52","author":"Lucas","year":"2000","journal-title":"Pharmacology Reviews"},{"issue":"5\u20136","key":"10.1016\/j.lfs.2010.05.002_bib19","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1159\/000129634","article-title":"Hypoxia inducible factor-1 improves the actions of nitric oxide and natriuretic peptides after simulated ischemia\u2013reperfusion","volume":"21","author":"Luciano","year":"2008","journal-title":"Cellular Physiology & Biochemistry"},{"issue":"2","key":"10.1016\/j.lfs.2010.05.002_bib20","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1097\/FJC.0b013e31802e84db","article-title":"Negative functional effects of natriuretic peptides are attenuated in hypertrophic cardiac myocytes by reduced particulate guanylyl cyclase activity","volume":"49","author":"Meyer","year":"2007","journal-title":"Journal of Cardiovascular Pharmacology"},{"issue":"1","key":"10.1016\/j.lfs.2010.05.002_bib21","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jss.2006.01.012","article-title":"Negative inotropic effects of C-type natriuretic peptide are attenuated in hypertrophied ventricular myocytes associated with reduced cyclic GMP production","volume":"135","author":"Moalem","year":"2006","journal-title":"Journal of Surgical Research"},{"issue":"2","key":"10.1016\/j.lfs.2010.05.002_bib22","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.jss.2006.01.015","article-title":"Heart failure reduces both the effects and interaction between cyclic GMP and cyclic AMP","volume":"134","author":"Moalem","year":"2006","journal-title":"Journal of Surgical Research"},{"issue":"1","key":"10.1016\/j.lfs.2010.05.002_bib23","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.gde.2003.12.006","article-title":"HIF-1 and hypoxic response: the plot thickens","volume":"14","author":"Poellinger","year":"2004","journal-title":"Current Opinions in Genetics & Development"},{"issue":"4","key":"10.1016\/j.lfs.2010.05.002_bib24","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s11936-007-0024-3","article-title":"Heart failure and cardiac hypertrophy","volume":"9","author":"Rame","year":"2007","journal-title":"Current Treatment Options in Cardiovascular Medicine"},{"issue":"10","key":"10.1016\/j.lfs.2010.05.002_bib25","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.lfs.2007.07.019","article-title":"Nitric oxide and cardiac function","volume":"81","author":"Rastaldo","year":"2007","journal-title":"Life Sciences"},{"issue":"43","key":"10.1016\/j.lfs.2010.05.002_bib26","doi-asserted-by":"crossref","first-page":"39805","DOI":"10.1074\/jbc.M107689200","article-title":"Regulation of the hypoxia-inducible factor 1alpha by the inflammatory mediators nitric oxide and tumor necrosis factor-alpha in contrast to desferroxamine and phenylarsine oxide","volume":"276","author":"Sandau","year":"2001","journal-title":"Journal of Biological Chemistry"},{"issue":"7134","key":"10.1016\/j.lfs.2010.05.002_bib27","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/nature05602","article-title":"p53-induced inhibition of Hif-1 causes cardiac dysfunction during pressure overload","volume":"446","author":"Sano","year":"2007","journal-title":"Nature"},{"issue":"6774","key":"10.1016\/j.lfs.2010.05.002_bib28","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/35004606","article-title":"Regulation of intracellular calcium by a signalling complex of IRAG, IP3 receptor and cGMP kinase Ibeta","volume":"404","author":"Schlossmann","year":"2000","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.lfs.2010.05.002_bib29","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/S0008-6363(03)00546-7","article-title":"Single L-type Ca2+ channel regulation by cGMP-dependent protein kinase type I in adult cardiomyocytes from PKG I transgenic mice","volume":"60","author":"Schroder","year":"2003","journal-title":"Cardiovascular Research"},{"issue":"4","key":"10.1016\/j.lfs.2010.05.002_bib30","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1152\/jappl.2000.88.4.1474","article-title":"HIF-1: mediator of physiological and pathophysiological responses to hypoxia","volume":"88","author":"Semenza","year":"2000","journal-title":"Journal of Applied Physiology"},{"issue":"8","key":"10.1016\/j.lfs.2010.05.002_bib31","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S1471-4914(01)02090-1","article-title":"Hypoxia-inducible factor 1: oxygen homeostasis and disease pathophysiology","volume":"7","author":"Semenza","year":"2001","journal-title":"Trends in Molecular Medicine"},{"issue":"3","key":"10.1016\/j.lfs.2010.05.002_bib32","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1152\/japplphysiol.00770.2003","article-title":"O2-regulated gene expression: transcriptional control of cardiorespiratory physiology by HIF-1","volume":"96","author":"Semenza","year":"2004","journal-title":"Journal of Applied Physiology"},{"issue":"2","key":"10.1016\/j.lfs.2010.05.002_bib33","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s11373-005-3008-x","article-title":"Carvedilol prevents cardiac hypertrophy and overexpression of hypoxia-inducible factor-1alpha and vascular endothelial growth factor in pressure-overloaded rat heart","volume":"12","author":"Shyu","year":"2005","journal-title":"Journal of Biomedical Science"},{"issue":"3","key":"10.1016\/j.lfs.2010.05.002_bib34","doi-asserted-by":"crossref","first-page":"H1367","DOI":"10.1152\/ajpheart.00880.2004","article-title":"Functional effects of C-type natriuretic peptide and nitric oxide are attenuated in hypertrophic myocytes from pressure-overloaded mouse hearts","volume":"288","author":"Su","year":"2005","journal-title":"American Journal of Physiology \u2014 Heart and Circulatory physiology"},{"issue":"6","key":"10.1016\/j.lfs.2010.05.002_bib35","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1161\/01.HYP.0000192651.06674.3f","article-title":"Lack of inducible NO synthase reduces oxidative stress and enhances cardiac response to isoproterenol in mice with deoxycorticosterone acetate\u2013salt hypertension","volume":"46","author":"Sun","year":"2005","journal-title":"Hypertension"},{"issue":"1","key":"10.1016\/j.lfs.2010.05.002_bib36","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1161\/HYPERTENSIONAHA.108.121822","article-title":"Deletion of inducible nitric oxide synthase provides cardioprotection in mice with 2-kidney, 1-clip hypertension","volume":"53","author":"Sun","year":"2009","journal-title":"Hypertension"},{"issue":"1","key":"10.1016\/j.lfs.2010.05.002_bib37","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1042\/BJ20070629","article-title":"Hypoxia, via stabilization of the hypoxia-inducible factor HIF-1alpha, is a direct and sufficient stimulus for brain-type natriuretic peptide induction","volume":"409","author":"Weidemann","year":"2008","journal-title":"Biochemical Journal"},{"issue":"6","key":"10.1016\/j.lfs.2010.05.002_bib38","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1124\/mol.106.024968","article-title":"Potential therapeutic gene for the treatment of ischemic disease: Ad2\/hypoxia-inducible factor-1alpha (HIF-1)\/VP16 enhances B-type natriuretic peptide gene expression via a HIF-1-responsive element","volume":"69","author":"Wilhide","year":"2006","journal-title":"Molecular Pharmacology"},{"issue":"11","key":"10.1016\/j.lfs.2010.05.002_bib39","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1161\/CIRCRESAHA.106.144501","article-title":"cAMP and cGMP signaling cross-talk: role of phosphodiesterases and implications for cardiac pathophysiology","volume":"100","author":"Zaccolo","year":"2007","journal-title":"Circulation Research"},{"issue":"3","key":"10.1016\/j.lfs.2010.05.002_bib40","doi-asserted-by":"crossref","first-page":"H1251","DOI":"10.1152\/ajpheart.01234.2003","article-title":"Reduction in interaction between cGMP and cAMP in dog ventricular myocytes with hypertrophic failure","volume":"289","author":"Zhang","year":"2005","journal-title":"American Journal of Physiology \u2014 Heart and Circulatory physiology"},{"issue":"1\u20134","key":"10.1016\/j.lfs.2010.05.002_bib41","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1159\/000104163","article-title":"Role of phospholamban in cyclic GMP mediated signaling in cardiac myocytes","volume":"20","author":"Zhang","year":"2007","journal-title":"Cellular Physiology & Biochemistry"},{"issue":"3","key":"10.1016\/j.lfs.2010.05.002_bib42","doi-asserted-by":"crossref","first-page":"189","DOI":"10.2174\/187152506777698344","article-title":"Cytokines and hormones in the regulation of hypoxia inducible factor-1alpha (HIF-1alpha)","volume":"4","author":"Zhou","year":"2006","journal-title":"Cardiovascular Hematological Agents in Medicinal Chemistry"},{"issue":"3","key":"10.1016\/j.lfs.2010.05.002_bib43","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.febslet.2004.09.041","article-title":"Suppression of P-glycoprotein gene expression in Hs578T\/Dox by the overexpression of caveolin-1","volume":"576","author":"Zhu","year":"2004","journal-title":"FEBS Letters"}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320510001992?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320510001992?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T21:28:56Z","timestamp":1740086936000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320510001992"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7]]},"references-count":43,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2010,7]]}},"alternative-id":["S0024320510001992"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2010.05.002","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2010,7]]}}}